BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31624316)

  • 21. Tobacco use and prostate cancer: 26-year follow-up of US veterans.
    Hsing AW; McLaughlin JK; Hrubec Z; Blot WJ; Fraumeni JF
    Am J Epidemiol; 1991 Mar; 133(5):437-41. PubMed ID: 2000853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Greatest percentage of involved core length and the risk of death from prostate cancer in men with highest Gleason score ≥ 7.
    Cheney MD; Chen MH; Zhang D; Phillips JG; Loffredo MJ; D'Amico AV
    Clin Genitourin Cancer; 2014 Aug; 12(4):234-40. PubMed ID: 24594503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. US Adult Interest in Less Harmful and Less Addictive Hypothetical Modified Risk Tobacco Products.
    O'Brien EK; Persoskie A; Parascandola M; Hoffman AC
    Nicotine Tob Res; 2018 Sep; 20(11):1317-1326. PubMed ID: 29059364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer.
    Raldow AC; Zhang D; Chen MH; Braccioforte MH; Moran BJ; D'Amico AV
    JAMA Oncol; 2015 Jun; 1(3):334-40. PubMed ID: 26181182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
    Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
    Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smoking history, intensity, and duration and risk of prostate cancer recurrence among men with prostate cancer who received definitive treatment.
    Khan S; Thakkar S; Drake B
    Ann Epidemiol; 2019 Oct; 38():4-10. PubMed ID: 31563295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediagnosis and postdiagnosis smoking and survival following diagnosis with ovarian cancer.
    Wang T; Townsend MK; Simmons V; Terry KL; Matulonis UA; Tworoger SS
    Int J Cancer; 2020 Aug; 147(3):736-746. PubMed ID: 31693173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between smoking at diagnosis and cause-specific survival in patients with rectal cancer: Results from a population-based analysis of 10,794 cases.
    Sharp L; McDevitt J; Brown C; Carsin AE; Comber H
    Cancer; 2017 Jul; 123(13):2543-2550. PubMed ID: 28297071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study.
    Gnanapragasam VJ; Lophatananon A; Wright KA; Muir KR; Gavin A; Greenberg DC
    PLoS Med; 2016 Aug; 13(8):e1002063. PubMed ID: 27483464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smoking Is Associated with Acute and Chronic Prostatic Inflammation: Results from the REDUCE Study.
    Moreira DM; Nickel JC; Gerber L; Muller RL; Andriole GL; Castro-Santamaria R; Freedland SJ
    Cancer Prev Res (Phila); 2015 Apr; 8(4):312-7. PubMed ID: 25644151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radical prostatectomy in Denmark: Survival analysis and temporal trends in clinicopathological parameters with up to 20 years of follow-up.
    Heering M; Berg KD; Brasso K; Iversen P; Røder MA
    Surg Oncol; 2017 Mar; 26(1):21-27. PubMed ID: 28317581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study.
    Clément-Duchêne C; Stock S; Xu X; Chang ET; Gomez SL; West DW; Wakelee HA; Gould MK
    Ann Am Thorac Soc; 2016 Jan; 13(1):58-66. PubMed ID: 26730864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Snus use, smoking and survival among prostate cancer patients.
    Wilson KM; Markt SC; Fang F; Nordenvall C; Rider JR; Ye W; Adami HO; Stattin P; Nyrén O; Mucci LA
    Int J Cancer; 2016 Dec; 139(12):2753-2759. PubMed ID: 27582277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Widespread Belief That Organic and Additive-Free Tobacco Products are Less Harmful Than Regular Tobacco Products: Results From the 2017 US Health Information National Trends Survey.
    Pearson JL; Moran M; Delnevo CD; Villanti AC; Lewis MJ
    Nicotine Tob Res; 2019 Jun; 21(7):970-973. PubMed ID: 30722066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significant association of brachytherapy boost with reduced prostate cancer-specific mortality in contemporary patients with localized, unfavorable-risk prostate cancer.
    Xiang M; Nguyen PL
    Brachytherapy; 2015; 14(6):773-80. PubMed ID: 26489921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A worse prognosis for smokers with prostate cancer.
    Daniell HW
    J Urol; 1995 Jul; 154(1):153-7. PubMed ID: 7776411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smoking and risk of fatal prostate cancer in a prospective U.S. study.
    Rohrmann S; Genkinger JM; Burke A; Helzlsouer KJ; Comstock GW; Alberg AJ; Platz EA
    Urology; 2007 Apr; 69(4):721-5. PubMed ID: 17445658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cigarette smoking and prostate cancer in a prospective US cohort study.
    Watters JL; Park Y; Hollenbeck A; Schatzkin A; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2427-35. PubMed ID: 19706848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Military Factors Associated with Smoking in Veterans.
    Golden SE; Thakurta S; Slatore CG; Woo H; Sullivan DR
    Mil Med; 2018 Nov; 183(11-12):e402-e408. PubMed ID: 29788494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The negative impact of tobacco smoking on survival after prostate cancer diagnosis.
    Polesel J; Gini A; Dal Maso L; Stocco C; Birri S; Taborelli M; Serraino D; Zucchetto A
    Cancer Causes Control; 2015 Sep; 26(9):1299-305. PubMed ID: 26134048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.